Literature DB >> 28643019

Antibody-based therapies for the treatment of brain metastases from HER2-positive breast cancer: time to rethink the importance of the BBB?

Vasileios Askoxylakis1, David P Kodack1, Gino B Ferraro1, Rakesh K Jain2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28643019     DOI： 10.1007/s10549-017-4351-0

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  2 in total

Review 1.  The Role of Stereotactic Biopsy in Brain Metastases.

Authors:  Kenny K H Yu; Ankur R Patel; Nelson S Moss
Journal:  Neurosurg Clin N Am       Date:  2020-08-14       Impact factor: 2.509

Review 2.  Management of brain metastases according to molecular subtypes.

Authors:  Riccardo Soffietti; Manmeet Ahluwalia; Nancy Lin; Roberta Rudà
Journal:  Nat Rev Neurol       Date:  2020-09-01       Impact factor: 42.937
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.